World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston
Bristol Myers Squibb at World CDx 2026
Oct 5–8, 2026 Boston, MA ~900 attendees Website
Bristol Myers Squibb takes part in 4 sessions at World CDx 2026 in Boston. Its sessions cover fair, worldwide access to cancer biomarker testing through standard testing pathways and scalable commercial drug-diagnostic plans. They also take in newer biomarker methods, from AI-powered computational pathology that moves past immunohistochemistry scoring to standard validation of tumor-informed minimal residual disease assays.
| Organization | World CDx 2026 Attendance |
|---|---|
Bristol Myers Squibb Princeton, NJ | |
Global pharmaceutical company with medicines in oncology, hematology, immunology and cardiovascular disease. | Panel Tue Oct 6 6:10pm Strengthening Tumor‑Informed MRD Assays with Standardized Analytical Validation to Ensure Reliable Detection & Confident Clinical Interpretation Liquid biopsy & MRDClinical & companion diagnostic development Panel Wed Oct 7 2:10pm Beyond IHC Scoring: Unlocking Next-Generation Clinical Biomarkers through AI-Powered Computational Pathology Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Panel Wed Oct 7 3:10pm Bolstering Scalable Commercial Drug-Diagnostic Strategies to Ensure Equitable Solutions for Global Precision Oncology Applications Drug–diagnostic commercialization & access Panel Thu Oct 8 9:00am Mobilizing Precision Cancer Care Through the Precision Cancer Consortium to Standardize Testing Pathways & Reduce Access Barriers Drug–diagnostic commercialization & access |
Instantly find 20 buyers from Bristol Myers Squibb
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by World CDx or its organizers. Submit a correction